AbbVie, Inc.
Không có giao dịch
Chứng khoán nợ doanh nghiệp
Dưới đây là danh sách trái phiếu AbbVie, Inc., được sắp xếp theo lợi suất đến ngày đáo hạn. Trong giai đoạn thị trường biến động, nhà đầu tư thường lựa chọn trái phiếu doanh nghiệp nhờ tính ổn định cao hơn. Hãy xem xét giá, lợi suất và các số liệu khác để tìm ra khoản đầu tư đáng tin cậy.
Mã | YTM % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7.00% | 26 K | 76.04% | 4.750% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6.40% | 12 K | 83.25% | 4.850% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6.38% | 124 K | 81.98% | 4.625% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5.79% | 250 K | 91.22% | 4.550% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| 5.57% | 1.76 M | 98.86% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.50% | 10.73 M | 98.57% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.49% | 26 K | 90.47% | 3.200% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.49% | 12.67 M | 101.56% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.46% | 658 K | 92.36% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.45% | 519 K | 92.01% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.44% | 18.94 M | 84.09% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.43% | 0 | 87.96% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.41% | 0 | 91.50% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.36% | 2.1 M | 94.17% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.32% | 5.96 M | 100.30% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.30% | 30 K | 92.23% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.27% | 0 | 90.34% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.04% | 3.21 M | 90.25% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.74% | 0 | 96.43% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.68% | 0 | 98.67% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.65% | 5.06 M | 99.28% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.64% | 3.87 M | 104.12% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.52% | 4.56 M | 103.52% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.10% | 1.96 M | 103.88% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.02% | 0 | 96.43% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
| 3.95% | 0 | 99.82% | 3.200% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.95% | 12.24 M | 103.44% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.90% | 6.98 M | 97.55% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.85% | 737 K | 102.74% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3.82% | 0 | 94.83% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
| 3.79% | 1.78 M | 101.16% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.75% | 13.05 M | 101.06% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.72% | 762 K | 101.80% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.66% | 2.07 M | 99.46% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.16% | 0 | 126.76% | 4.750% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 128.71% | 4.850% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 121.31% | 4.250% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.92% | 0 | 91.24% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.60% | 0 | 98.75% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.59% | 0 | 98.55% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.57% | 0 | 123.74% | 4.550% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.52% | 0 | 100.27% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.37% | 0 | 97.24% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| −5.92% | 0 | 98.80% | 2.950% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| — | — | — | 4.400% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |